A Florida lawsuit alleging artificial intelligence contributed to a patient’s delayed cancer diagnosis is forcing renewed scrutiny of liability as AI is integrated into clinical workflows. As hospitals deploy machine learning tools for image interpretation and decision support, responsibility for diagnostic errors may shift among vendors, clinicians and health systems. Legal claims could invoke negligence, product liability and failure-to-warn theories, while the opaque “black box” nature of many models and limited FDA oversight exacerbate uncertainty about who bears risk when algorithms err.
Health systems and IT leaders are responding by tightening procurement contracts, demanding vendor transparency, documenting human oversight, and implementing algorithm governance, testing and post-market monitoring to reduce exposure. Insurers, regulators and courts will shape precedent, but for now the patchwork regulatory environment and gaps in explainability leave providers facing reputational, financial and legal risks as AI becomes core to diagnosis.
